Tris Pharma to Debut Positive Results of Intranasal (Snorting) Human Abuse Potential Study …

The FDA granted Fast Track Designation to cebranopadol for chronic low back pain, and if approved, it could become the first dual-NMR pain-relief …
Source: back pain